Ocugen (OCGN) announces FDA has issued clinical hold on IND to evaluate the COVID-19 vaccine candidate, COVAXIN

Go back to Ocugen (OCGN) announces FDA has issued clinical hold on IND to evaluate the COVID-19 vaccine candidate, COVAXIN

Ocugen (OCGN) Halted on LUDP

November 26, 2021 9:38 AM EST

Ocugen (NASDAQ: OCGN) Halted on LUDP

... More